{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:27:00Z","timestamp":1786602420983,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["cstc2021jscx-dxwtBX0016"],"award-info":[{"award-number":["cstc2021jscx-dxwtBX0016"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Artemisinin regulates the immune system and is applied in RA treatment. Nevertheless, the effectiveness and potential mechanisms of artemisinin in the treatment of RA remain unclear, especially in fibroblast-like synoviocytes (FLSs). This study aimed to investigate the mechanism of artemisinin in the treatment of rheumatoid arthritis (RA) through an integrated network pharmacology and bioinformatics approach, supported by experimental validation both in MH7A cells and collagen-induced arthritis (CIA) mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SwissTargetPrediction database, TCMSP, TargetNet, SuperPred, and PharmMapper were used to identify the targets of artemisinin. RA-related differentially expressed genes (DEGs) were collected by integrating three GEO datasets. DEGs related to artemisinin were utilized to create protein-protein interaction networks and visualize them with STRING and Cytoscape. GO and KEGG functional enrichment analyses were executed. Molecular docking and molecular dynamics (MD) simulations were carried out to analyze core targets using the AutoDock Vina and Desmond software. Furthermore, CIA mouse and MH7A cells were used to validate the results obtained from network pharmacology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 73 target genes intersecting between the artemisinin targets and the DEGs. PPI network analysis and its topology indicated that AR, EGFR, JAK2, and PTGS2 had the greatest centrality. GO and KEGG enrichment analyses suggested that the candidate targets were significantly associated with the PI3K\/AKT signaling pathway. Molecular docking and an in vivo study were used for further investigation. Artemisinin interacted with the cavities of AR, JAK2, EGFR, and PTGS2 with binding energies of \u20138.65, \u20138.61, \u20137.48, and \u20138.48 kcal\/mol, respectively. MD simulations showed that the AR\u2013artemisinin complex maintained persistent interactions and stable energy profiles over 20 ns. The CIA model and MH7A cell studies confirmed that artemisinin exposure inhibited the proliferation and production of IL-1\u03b2, IL-6, and IL-8 triggered by IL-17. Furthermore, artemisinin attenuated IL-17-induced AKT phosphorylation levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that artemisinin may ameliorate RA partly by suppressing IL-17-induced inflammatory activation and PI3K\/AKT signaling. AR, EGFR, JAK2, and PTGS2 were prioritized as candidate hub targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1862104","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:32:02Z","timestamp":1786599122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artemisinin ameliorates rheumatoid arthritis through modulation of the IL-17\/PI3K\/AKT signaling pathway: integrated network pharmacology, bioinformatics, and experimental validation"],"prefix":"10.3389","volume":"17","author":[{"given":"Zongyuan","family":"Zhou","sequence":"first","affiliation":[{"name":"Antibiotic Innovation and Resistance Control Key Laboratory of Sichuan Province, National Base for International Science and Technology Cooperation, School of Pharmacy, Chengdu University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[{"name":"Antibiotic Innovation and Resistance Control Key Laboratory of Sichuan Province, National Base for International Science and Technology Cooperation, School of Pharmacy, Chengdu University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzuo","family":"Li","sequence":"additional","affiliation":[{"name":"Antibiotic Innovation and Resistance Control Key Laboratory of Sichuan Province, National Base for International Science and Technology Cooperation, School of Pharmacy, Chengdu University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Chengdu University, Chengdu University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Qin","sequence":"additional","affiliation":[{"name":"Antibiotic Innovation and Resistance Control Key Laboratory of Sichuan Province, National Base for International Science and Technology Cooperation, School of Pharmacy, Chengdu University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Qiang","sequence":"additional","affiliation":[{"name":"Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine, Chongqing Academy of Chinese Materia Medica, Chongqing University of Chinese Medicine","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: Extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216243","article-title":"Economic burden of rheumatoid arthritis: A systematic review of literature in biologic era","volume":"79","author":"Hsieh","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00070-X","article-title":"Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (Miracle): A randomised, open-label, non-inferiority trial","volume":"5","author":"Tamai","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115300","article-title":"Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers","volume":"208","author":"Chapa-Villarreal","year":"2024","journal-title":"Adv Drug Delivery Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin","volume":"216","author":"Ma","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2579","article-title":"Artemisinin inhibits monocyte adhesion to Huvecs through the Nf-Kappab and Mapk pathways in vitro","volume":"37","author":"Wang","year":"2016","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2253436","article-title":"Targeting inhibition of accumulation and function of myeloid-derived suppressor cells by artemisinin via Pi3k\/AKT, Mtor, and Mapk pathways enhances anti-Pd-L1 immunotherapy in melanoma and liver tumors","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15302","article-title":"Artemisinin inhibits Tlr4 signaling by targeting co-receptor Md2 in microglial Bv-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice","volume":"157","author":"Zhang","year":"2021","journal-title":"J Neurochem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70086","article-title":"Artemisinins in autoimmune diseases: Effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis","volume":"182","author":"Zhou","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176551","article-title":"Small-molecule targeting Pkm2 provides a molecular basis of lactylation-dependent fibroblast-like synoviocytes proliferation inhibition against rheumatoid arthritis","volume":"972","author":"Wang","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.10.015","article-title":"Dihydroartemisinin derivative Dc32 attenuates collagen-induced arthritis in mice by restoring the Treg\/Th17 balance and inhibiting synovitis through down-regulation of Il-6","volume":"65","author":"Fan","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02762","article-title":"Dc32, a dihydroartemisinin derivative, ameliorates collagen-induced arthritis through an Nrf2-P62-Keap1 feedback loop","volume":"9","author":"Fan","year":"2018","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.34133\/research.0459","article-title":"Dihydroartemisinin regulated the Mmp-mediated cellular microenvironment to alleviate rheumatoid arthritis","volume":"7","author":"Guo","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1717045","article-title":"Artemisinin exerts anti-inflammatory effects in osteoarthritis through the inhibition of Tgf-Beta1 signaling","volume":"17","author":"Zheng","year":"2026","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.07.087","article-title":"Anti-inflammatory effect of artemisinin on uric acid-induced Nlrp3 inflammasome activation through blocking interaction between Nlrp3 and Nek7","volume":"517","author":"Kim","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2010.580","article-title":"The anti-malarial artemisinin inhibits pro-inflammatory cytokines via the Nf-Kappab canonical signaling pathway in Pma-induced Thp-1 monocytes","volume":"27","author":"Wang","year":"2011","journal-title":"Int J Mol Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ani11061528","article-title":"Artemisinin protects porcine mammary epithelial cells against lipopolysaccharide-induced inflammatory injury by regulating the Nf-Kappab and Mapk signaling pathways","volume":"11","author":"Zhang","year":"2021","journal-title":"Anim (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.176","article-title":"Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum","volume":"3","author":"Gao","year":"2024","journal-title":"Imeta"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.08.016","article-title":"Resistance to artemisinin in falciparum malaria parasites: A redox-mediated phenomenon","volume":"179","author":"Egwu","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.schres.2011.04.010","article-title":"Artemisinin reduces the level of antibodies to gliadin in schizophrenia","volume":"129","author":"Dickerson","year":"2011","journal-title":"Schizophr Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s13063-023-07790-3","article-title":"Schistoact: A protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection","volume":"24","author":"Obonyo","year":"2023","journal-title":"Trials"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5326\/JAAHA-MS-6145","article-title":"Comparison of high-dose intermittent and low-dose continuous oral artemisinin in dogs with naturally occurring tumors","volume":"50","author":"Hosoya","year":"2014","journal-title":"J Am Anim Hosp Assoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11655-016-2650-7","article-title":"Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial","volume":"23","author":"Yang","year":"2017","journal-title":"Chin J Integr Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3110-z","article-title":"A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee","volume":"35","author":"Stebbings","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B27","first-page":"97","article-title":"An open-label six-month extension study to investigate the safety and efficacy of an extract of Artemisia annua for managing pain, stiffness and functional limitation associated with osteoarthritis of the hip and knee","volume":"129","author":"Hunt","year":"2016","journal-title":"N Z Med J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.34133\/research.0003","article-title":"In situ-activated phospholipid-mimic artemisinin prodrug via injectable hydrogel nano\/microsphere for rheumatoid arthritis therapy","volume":"2022","author":"Du","year":"2022","journal-title":"Res (Wash D C)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.08.054","article-title":"An Ros-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the Hif-1\u03b1\/Nf-\u03bab cascade regulation of Ros scavenging and macrophage repolarization","volume":"152","author":"Li","year":"2022","journal-title":"Acta Biomater"},{"key":"B30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13075-019-1935-6","article-title":"A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients","volume":"21","author":"Ma","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med Res Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1002\/med.21848","article-title":"The newly discovered role of endocytosis in artemisinin resistance","volume":"41","author":"Behrens","year":"2021","journal-title":"Med Res Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.03.007","article-title":"Unpacking 'artemisinin resistance'","volume":"38","author":"Wang","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185698","article-title":"Molecular basis of artemisinin derivatives inhibition of myeloid differentiation protein 2 by combined in silico and experimental study","volume":"26","author":"Qiao","year":"2021","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/c9ob01264h","article-title":"Identification of Hsp90 as a direct target of artemisinin for its anti-inflammatory activity via quantitative chemical proteomics","volume":"17","author":"Wu","year":"2019","journal-title":"Org Biomol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01378-6","article-title":"Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting Keap1","volume":"46","author":"Deng","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.07.012","article-title":"Artemisinin inhibits Nras palmitoylation by targeting the protein acyltransferase Zdhhc6","volume":"29","author":"Qiu","year":"2022","journal-title":"Cell Chem Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00794","article-title":"Androgen-induced immunosuppression","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055483","article-title":"Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: Is there a link to inflammation","volume":"66","author":"Capellino","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S403422","article-title":"Exploration of artemisinin against Iga nephropathy via AKT\/Nrf2 pathway by bioinformatics and experimental validation","volume":"17","author":"Yang","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1961-4","article-title":"Association of rheumatoid arthritis risk with Egfr genetic polymorphisms in Taiwan's Han Chinese population","volume":"32","author":"Lo","year":"2012","journal-title":"Rheumatol Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156171","article-title":"Acacetin alleviates rheumatoid arthritis by targeting Hsp90 Atpase domain to promote Cox-2 degradation","volume":"135","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00548-w","article-title":"A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating Tnf-alpha-dependent receptor clustering","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224479","article-title":"New biologic (Ab-Ipl-Il-17) for Il-17-mediated diseases: Identification of the bioactive sequence (Nil-17) for Il-17a\/F function","volume":"82","author":"Saviano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141008","article-title":"Il-1beta-driven osteoclastogenic Tregs accelerate bone erosion in arthritis","volume":"131","author":"Levescot","year":"2021","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154875","article-title":"Tubson-2 decoction ameliorates rheumatoid arthritis complicated with osteoporosis in Cia rats involving isochlorogenic acid a regulating Il-17\/Mapk pathway","volume":"116","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114791","article-title":"Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating Nf-Kappab and Mapk signaling pathways","volume":"284","author":"Shen","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/srep38115","article-title":"Artemisinin analogue Sm934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells","volume":"6","author":"Lin","year":"2016","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4232","article-title":"Artesunate influences Th17\/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis","volume":"13","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.11","article-title":"The new water-soluble artemisinin derivative Sm905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses","volume":"153","author":"Wang","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem014","article-title":"Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/AKT signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatol (Oxford)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862104\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:32:04Z","timestamp":1786599124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862104\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2026.1862104"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1862104","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1862104"}}